Status:
RECRUITING
1% Lidocaine Paracervical Block for Endometrial Biopsy
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Endometrial Biopsy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of this study is to to determine whether 1% lidocaine paracervical block reduces pain during endometrial biopsy in comparison to no intervention. The proposed study is a double-blind ra...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Any participant \> or = age 18 years old presenting for an endometrial biopsy
- All parities of patients are eligible
- English speaking participants only
- Exclusion Criteria
- Use of pain medication that is not an NSAID or acetaminophen (e.g. opioids, benzos) within past 24 hours
- Confirmed pregnancy
- Any diagnosed chronic pain syndromes (eg. fibromyalgia, vaginismus, interstitial cystitis)
- Contraindication to lidocaine
- Misoprostol administration within 24 hours
- Previous unsuccessful office attempt at endometrial biopsy by the same practitioner (note of clarification: previous unsuccessful biopsy attempt by a different practitioner will still be eligible)
Exclusion
Key Trial Info
Start Date :
June 19 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06546254
Start Date
June 19 2025
End Date
December 31 2025
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OPG
Toronto, Ontario, Canada, M5G 1Z5